Bibliographie
OUVRAGES
Anonyme
Amphetamine-type stimulants. WHO/MSA/PSA/97.5
Geneva : WHO ; 1997.
Anonyme
Drogues et toxicomanies : Indicateurs et tendances.
Paris : OFDT ; 1996.
Briggs GG, Freeman RK, Yaffe SJ.
Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk.
Baltimore : Williams and Wilkins ; 1994.
Carter RHA
Pharmacodépendance et pharmacodélinquance.
Paris : Chiron ; 1990.
Cox TC, Jacobs MR, Eugene-Leblanc A, Marshman JA
Drugs and drug abuse.
Toronto : Addiction research foundation ; 1983.
Fontaa V, Senninger JL
Le médecin et le toxicomane : Guide pratique.
Thoiry : Editions heures de France ; 1996.
Dukes MNG Editor
Meyler's side effects of drugs 13th ed
Amsterdam : Elsevier ; 1996.
Galanter M, Kleber HD
Textbook of substance abuse treatment.
Washington : American Psychiatric Press ; 1994.
Giroud JP, Mathé G, Meniel G
Pharmacologie clinique bases de la thérapeutique. 2è éd
Paris : Expansion Scientifique Française 1988.
Greist JH, Jefferson JW, Spitzer RL
Treatment of mental disorders.
New York : Oxford University Press ; 1982.
Hardman JG, Linbrid LE
Goodman & Gilman's : The pharmaceutical basis of therapeutics.
New York : Mac Graw-Hill ; 1996.
Heim R
Les champignons toxiques et hallucinogènes.
Paris : Société nouvelle des éditions Boubée ; 1978.
Kintz P
Toxicologie et pharmacologie médicolégales.
Paris :Elsevier option bio ; 1998.
Inaba DS, Cohen WE
Excitants, calmants, hallucinogènes. Effets physiques et mentaux des drogues et autres produits actifs sur le psychisme.
Padova : Piccin ; 1997.
Mendelson JH, Mello NK
Cocaïne and other commonly abused drugs. In : Harrison's principles of internal medicine.
13th ed , : Mc Graw Hill ; 1994. P. 2429-33.
Pelt JM
Drogues et plantes magiques.
Paris : Fayard ; 1983.
Porot A
Manuel alphabétique de psychiatrie.
Paris : PUF ; 1984.
Reynolds JEH Editor
Martindale The Extra Pharmacopoeia 31th ed
London : Royal Pharmaceutical Society ; 1996.
Roques BP
La dangerosité des drogues : rapport au Secrétariat d'Etat à la Santé.
Paris : Odile Jacob ; 1998.
Stockley IV
Drug interactions.
London : The Pharmaceutical Press ; 1996.
Young LY, Koda-Kimble MA Editors
Applied Therapeutics : the clinical use of drugs. 6th ed
Vancouver : Applied Therapeutics ;1995.
BIBLIOGRAPHIE ELECTRONIQUE
Rumack BH, Toll LL, Gelman CR Editors
Poisindex System.
Micromedex, Inc, Englewood, Colorado (Edition expires 1999).
Hall AH Editor
Reprorisks System.
Micromedex, Inc, Englewood, Colorado (Edition expires 1999).
Hall AH Editor
Reprotex System.
Micromedex, Inc, Englewood, Colorado (Edition expires 1999).
PERIODIQUES
Articles généraux
Charles-Nicolas A
Toxicomanies.
Encycl. Med; Chir. Psychiatrie 37-396-A-10, 1998.
Haramburu F, Neveu D, Jouglard J
Lexique argotique de la drogue.
La Lettre du Pharmacologue 1998 ;12(5):102-6.
Martin R, Bogousslavsky J
Angiopathies cérébrales toxiques.
Encycl med Chir (Elsevier Paris) Neurologie 17-046-B-06, 1996, 6p.
Pham A, Guelfi JD
Hallucinations : orientation diagnostique.
Rev Prat 1998 ; 47 : 1473-5.
Pommier F
Dépendance à l'égard des drogues illicites.
EMC Toxicologie - Pathologie professionnelle 16-001-G-60, 1993.
Alcool
Anonyme
Naltrexone : une effet transitoire sur l'abstinence alcoolique.
La Revue Prescrire 1998 ; 18(186):483-5.
Batel P
Sevrage en milieu hospitalier.
Rev Prat 1999 ; 49(4):387-90.
Fourestié V
Le syndrome de sevrage d'alcool est une urgence dont le traitement a évolué.
Rev Prat 1998 ; 12(431):9-12.
Froehlich JC, Badia-Elder NE, Zink RW
Contribution of the opioid system to alcohol aversion and alcohol drinking behavior.
J Pharmacol Exp Ther 1998 ; 287:284-92.
Gache P
Repérage et diagnostic des malades de l'alcool.
Rev Prat 1999 ; 49(4):375-78, 1999.
Garcia-Monco JC, Beldarrain MG
Patients with alcohol problems.
New Engl J Med 1998 ; 339:130.
Gorwood P
Alcoolodépendance et dépression.
Rev Praticien 1999 ; 49(4):391-94.
Huas D, Pessionne F
Les consommateurs d'alcool à problèmes.
La Revue du Praticien 49(4):379-82, 1999.
Manus A
Alcoolisme : complications psychiatriques aiguës et chroniques.
Rev Prat 1994 ; 44(18):421-4.
Marchal C
Alcool et épilepsie.
Rev Prat 1999 ; 49(4):383-6.
O'Connor, Schottenfeld RS
Patients with alcohol problems.
New Engl J Med 1998 ; 338(9):592-602.
Paille F, Dupasquier F
Comment devient-on psychiquement dépendant de l'alcool ?
Rev Prat 1998 ; 12(430):9-15.
Rueff U
Evaluation des traitements médicamenteux de l'alcoolodépendance psychique primaire.
Rev Praticien 1999 ; 49(4):400-2.
Sangla I, Bille-Turc F, Pouget J
Accident vasculaire cérébral ischémique comtemporain d'une intoxication alcoolique aiguë chez un sujet jeune.
Presse Med 1995 ; 24(17):827.
Schlienger JL
Effets bénéfiques et délétères des boissons alcooliques.
Rev Prat 1999 ; 49(4):367-72.
Sereni C, Degos CF
Atteintes du tronc cérébral et du cervelet d'origine alcoolique et carentielle.
Rev Praticien 1990 ; 40(13):1193-6.
Stoler JM, Huntington KS, Peterson CM
The prenatal detection of significant alcohol exposure with maternal blood markers.
J Pediatr 1998 ; 133(3):346-351.
Uehlinger C
Approche cognitivo-comportementale du traitement de l'alcoolodépendance psychique.
Rev Prat 1999 ; 49(4):395-99.
Vabret F, Davy A
Le sevrage alcoolique est réalisable en ambulatoire.
Rev Praticien 1998 ; 12(141):9-13.
Amineptine
Anomyme.
Risque de toxicomanie à l'amineptine.
La Revue Prescrire 1994 ; 14 (141) 342.
Castot A, Benzaken C, Wagniart F, Efthymiou ML
Surconsommation d'amineptine.
Therapie 1990 ; 45 : 399-405.
Vandel S, Bertschy G, Bizouard P, Luxembourger I, Allers G, Volmat R
Modalité d'installation d'une dépendance à l'amineptine.
Therapie 1990 ; 45 : 51.
Vexiau P et al
Severe acne-like lesions caused by amineptine overdose.
Lancet 198 : i, 585.
Amphétamines
Anonyme
Methamphetamine abuse and addiction
NIDA Research Report 98-4210.
Clark J, Milroy C, Rutty G
Marfan's syndrome might have been factor in acute dissection of aorta in amphetamine misuser.
Br Med J 1997 ; 315(7116):1163.
Mc Ketin R, Mattick RP
Attention and memory in illicit amphetamine users : comparison with non-drug-using controls.
Drug Alcohol Depend 1998 ; 50:181-4.
Meng Y, Dukat M, Bridgen DT
Pharmacological effects of methamphetamine and other stimulants via inhalation exposure.
Drug Alcohol Depend 1999 ; 53:111-120.
Oro AS, Dixon SD
Perinatal cocaïne and methamphetamine exposure : maternal and neonatal correlates.
J Pediatr 1987 ; 111(4):571-8.
Anorexigènes
Anonyme
Valvulopathies dues aux anorexigènes.
La Revue Prescrire 1999 ; 19:204-5.
Chaplin S
Adverse effects of drugs used for weight reduction.
Adverse Drug React Bull 1991 ; 148:556-9.
Khan SA, Spiegel DA, Jobe PC
Psychotomimetic effects of anorectic drugs.
Am Fam Phys 1987 ; 36(2):107-2.
Silverstone T
Appetite suppressants : a review.
Drugs 1992 ; 43:820-36.
Vivero LE, Anderson PO, Clark RF
A close look at fenfluramine and dexfenfluramine.
J Emerg Med 1998 ; 16(2):197-205.
Williams DM
Phenylpropanolamine hydrochloride.
American Pharmacy 1990 ; NS 30(10):47-50.
Young R, Darmani NA, Elder EL
Clobenzorex :evidence for amphetamine-like behavioral actions.
Pharmacol Biochem Behav 1997 ; 56(2):331-6.
Anticholinergiques
Montastruc JL, Tran MA
Atropine : principes et règles d'utilisation.
Rev Prat 1998 ; 48:85-7.
Antihistaminiques
De Nesnera AP
Diphenhydramine dependence : a need for awareness.
Journal of Clinical Psychiatry 57:136-7, 1996.
Dinndorf PA, McCabe MA, Frierdich S
Risk of abuse of diphenhydramine in children and adolescent with chronic illnesses.
J Pediatr 1998 ; 133(2):293-5.
Kavanagh GM, Charlwood MR, Peachey RD
Withdrawal symptoms after discontinuation of long-acting brompheniramine maleate.
British Journal of Dermatology 131:913-4, 1994.
Sansone M
Antihistaminic-opioïd combination : effect on locomotoor activity in mice.
Pol J Pharmacol 1988 ; 40(5):515-23.
Suzuki T, Mori T, Tsuji M
Interactions between H1 antagonists and opioids : a drug discrimination study.
Psychopharmacology 1997 ; 131:346-53.
Antalgiques
Kaube H, May A, Diener HC
Sumatriptan
Br Med J 1994 ; 308:1573-4.
Osborne MJ, Austin RCT, Dawson KJ
Is there a problem with long terme use of sumatriptan in acute migraine?
Br Med J 1994 ; 308:113-8.
Symon DNK
Twelve cases of analgesic headache.
Arch Dis Child 1998 ; 78:555-6.
Antidépresseurs
Anonyme
Antidépresseurs inhibiteurs de la recapture de la sérotonine et grossesse.
La Revue Prescire 1999 :19(192):127-9.
Debattista C, Schatzerg AF
Physical symptoms associated with paroxetine withdrawal.
Am J Psychiatry 1995 ; 152(8):1235-6.
Dilsaver SC
Withdrawal phenomena associated with antidepressant and psychotic agents.
Drug Saf 1994 ; 10 (2):103-14.
Haddad P, Lejoyeux M, Young A
Antidepressant discontinuation reactions.
Br Med J 1998 ; 316: 1105-6.
Pagliaro LA, Pagliaro AM
Abuse potential of antidepressants : does it exist ?
CNS Drugs 1995 ; 4(4):247-52.
Pringuey D, Azorin JM, Bottai T, Perrier E
La dépendance aux antidépresseurs et aux neuroleptiques.
Psychol Med 1989 ; 21(14):2073-5.
Vanelle JM, Feline A
Arrêt du traitement médicamenteux dans la dépression.
Encephale 1994 ; 20 Suppl 1:223-9.
Pagliaro LA, Pagliaro AM
Abuse potential of antidepressants : does it exist ?
CNS Drugs 1995 ; 4(4)247-52.
Schatzberg AF, Haddag P, Kaplan EM
Serotonin reuptake inhibitor discontinuation syndrome : a hypothetical definition.
J Clin Psychiatry 1997 ; 58 Suppl 7:5-10.
Zajecka J, Tracy KA, Mitchel S
Discontinuation symptoms after treatment with serotonin reuptake inhibitors : a literature rewiev.
J Clin Psychiatry1997 ; 58(7):291-7.
Aspects cliniques
Benson MK, Bentley AM
Lung disease induced by drug addiction.
Thorax 1995 ; 50:1125-7.
Cohen SI
Overdiagnosis of schizophrenia : role of alcool and misuse.
Lancet 1995; 346:1541-2.
Fari A
Infection graves chez les toxicomanes intraveineux.
La Revue Prescrire 1991 ; 108:318-9.
Gillman PK
Serotonin syndrome : history and risk.
Fundam Clin Pharmacol 1998 ; 12(5):482-91.
Haettich B, Kaplan G
Complications ostéo-articulaires chez les toxicomanes.
Le Concours Médical 1991 ;113(30):2616-22.
Perron JL, Laquielle X, Rémi-Boussière P
Les complications médicales des toxicomanies.
La Gazette Médicale 1986 ;93(41):45-51.
Benzodiazépines
Anonyme
Polytoxicomanie et traitement de substitution. Usage et mésusage des benzodiazépines chez les usagers de drogues (1ère partie)
Act. Med. Int. Psychiatrie 1997 ; 203(14):3476-7.
Anonyme
Polytoxicomanie et traitement de substitution. Usage et mésusage des benzodiazépines chez les toxicomanes (2ème partie)
Act. Med. Int. Psychiatrie 1997 ; 203(14):3476-7.
Anonyme
Dysphagie due aux benzodiazépines.
La Revue Prescrire 1999 ; 19(192):123-4.
Bobon D
Les bases biologiques de la pharmacodépendance : les benzodiazépines.
Rev Med Liege 1986 ; 61(5):165-73.
Pelissolo A, Bisserbe JC
Dépendance aux benzodiazépines. Aspects cliniques et biologiques.
Encephale 1994 ; XX:147-57.
Parquet PJ, Bailly D, Servant D
Les médicaments du sevrage des toxicomanies.
Psychol Med 1989 ; 21(13):2012-6.
Poirier MF, Ginestet D
Médicaments détournés de leur usage à des fins toxicomaniaques.
Rev Prat 1995 ; 45 :1364-6.
Quinn DI, Wodak A, Day RO
Pharmacokinetic and pharmacodynamic principles of illicit drug use and traetment of illicit drug users.
Clin. Pharmaokinet. 1997 ; 33(5):344-400.
Reynaud M, D'Elloy-Giraud E, Turbe S, Chassaing JL, Coudert AJ
Benzodiazépines : consommation au long cours et toxicomanie. Profil des consommateurs en milieu psychiatrique.
Psychotropes 1992 ; 7(2):55-65.
Buprénorphine
Marquet P, Chevrel J, Lavignasse P
Buprenorphine withdrawal syndrome in a newborn.
Clin Pharmacol Ther 1997 ; 62(5):569-71.
Regini P, Cutrone M, Donzelli F
Neonatal buprenorphine withdrawal syndrome, what is the right therapy ?
Pediatr Med Chir 1998 ; 20(1):67-9.
Caféine
Daly JW, Fredholm BB
Caffeine, an atypical drug of dependence.
Drug Alcohol Depend 1998 ; 51:199-206.
Hughes JR, Higgins ST, Bickel WK
Caffeine self administration, withdrawal and adverse effects among coffee drinkers.
JAMA 1992 ; 17:238.
Pickworth WB
Caffeine dependence.
Lancet 1995 ; 345:1066.
Rush CR, Sullivan JT, Griffiths RR
Intravenous caffeine in stimulant drug abusers : subjective reports ans physiological effects.
J Pharmacol Exp Ther 1995 ; 273(1):351-8.
Schuh KJ, Grffiths RR
Caffeine reinforcement : the role of withdrawal.
Psychopharmacology 1997 ; 130(4):320-6.
Cannabis
Diana M, Melis M, Muntoni AL, Gessa GL
Mesolimbic dopaminergic decline after cannabinoid withdrawal
Proc Natl Acad Sci 1999 ; 95:10269-73.
Hall W, Solavij N
Adverse effects of cannabis.
Lancet 1998 ; 352:1611-16.
Haney M, Ward AS, Comer SD, Foltin RW, Fishman MW
Abstinence symptoms following smoked marijuana in humans.
Psychopharmacology 1999 ; 141:395-404.
Holsten F
Flashbacks : a personnal follow up.
Archiv fur Psychiatrie und Nervenkrankheiten 1976 ; 222(4):293-304.
Kyndt X, Ducq P, Reumaux D
Artérite du cannabis versus maladie de Léo Buerger.
Presse Med 1999 ; 28(2):71-4.
Stanton MD, Mintz J, Franklin RM
Drug flashbacks II Some additionnal findings
International Journal of Addictions1976 ; 11(1):53-69.
Wieviorka S
Aspects médico-psychologiques de la consommation de cannabis.
Rev Prat 1995 ; 45:1367-70.
Yager J, Crumpton E, Rubenstein R
Flashbacks among soldiers discharged as unfit who abused more than one drug.
Am J Psychiatry 1983 ; 140(7):857-61.
Chocolat
Favre-Bismuth C, Gronzman E
Chocolatomanies : le fait et les raisons.
Sem Hop Paris 1985 ; 61(35-36):2583-6.
Zarifian E
La toxicomanie au chocolat existe-t-elle ?
Le Concours Medical 1993 ; 115(8):3442-3.
Cocaïne
Benson MK, Bentley AM
Lung disease induced by drug addiction.
Thorax 1995 ; 50 : 1125-7.
Clemessy CL, Baud FJ
Intoxication aiguë par les opiacés , la cocaïne et l'ecstasy.
Le Concours Medical 1998 ; 120(01):24-7.
Cregler LL, Herbert M
Medical complications of cocaïne abuse.
New Engl J Med 1986 ; 315 (23):1495-1500.
Delanay-Black V, Covington C, Templin T, Ager J, Martier S, Sokol R
Prenatal cocaïne exposure and child behavior.
Pediatrics 1998 ; 102(4):945-50.
Fox BS
Development of a therapeutic vaccine for the treatment of cocaine addiction.
Drug Alcohol Depend 1997 ; 48:153-8.
Gorelick DA
Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.
Drug Alcohol Depend 1997 ; 48:159-65.
Kaufman MJ, Levin JM, Ross MH
Cocaïne induced cerebral vasoconstriction detected in humans with magnetic resonance angiography.
JAMA 1998 ; 279 : 376-380.
Marzuk PM, Tardiff K, Leon AC
Ambient temperature and mortality from unintentional cocaïne overdose.
JAMA 1998 ; 279 (22) : 1795-1800.
Quinn DI, Wodak A, Day RO
Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.
Clin. Pharmacokinet. 1997 ; 33(5):344-400.
Sparenberg S, Vocci F, Zukin S
Peripheral cocaïne-blocking agents : new medication for cocaïne dependence.
Drug Alcohol Depend 1997 ; 48:149-51.
Van Viet H, Chevalier P, Sereni C, Bornet P, Bautier P, Degos CF
Accidents neurologiques liés à l'usage de la cocaïne.
Presse Med 1990 ; 19(22):1045-9.
Corticoïdes
Poirier MF,Ginestet
Médicaments détournés de leur usage à des fins toxicomaniaques.
Revue Prat 1995 ; .
De Carvalho W, Courimaux L
Potentialités psychotropes des médicaments anti-inflammatoires.
L'Encéphale 1997 ; 23(45):49-57.
Dimethyltryptamine
Strassman JR, Qualls CR, Berg CM
Differential tolerance to biological and subjective effects of 4 closely spaced doses of DMT in human.
Biol Psychiatry 1996 ; 39(9):784-95.
DOB
Buchanan JF, Brown CR
Designer drugs : a problem in clinical toxicology
Clinical Toxicology Review 1988 ; 3:1-17.
DOM
Buchanan JF, Brown CR
Designer drugs : a problem in clinical toxicology
Clinical Toxicology Review 1988 ; 3:1-17.
Fentanyl
Marquardt KA, Tharratt RS
Inhalation abuse of fentanyl patch.
Clinical Toxicology 1994 ; 32(1):75-8.
Flunitrazépam
Anonyme
La Revue Prescrire 1997 ; 173.
Woods JH, Winger G
Abuse liability of flunitrazépam
J Clin Psychopharmacol 1997 ; 17(3 Suppl 2):1-57.
Harmaline
Abdel-Fattah AF, Matsumoto K, Murakami Y
Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargylin and harmaline preteated rats.
Gen Pharmacol 1997 ; 28 (3):405-9.
Du W, Aloyo VJ, Harvey JA
Harmaline competitively inhibits 3H MK-801binding to the NMDA receptor in rabbit brain.
Brain Res 1997 ; 770(1-2):26-9.
Weiss M, Buldakova S, Dutova E
Interaction of the betacarboline harmaline with a GABA-benzodiazépine mechanism : an electrophysiological investigation on rat hippocampal slice.
Brain Res 1995 ; 695 (2):105-9.
Ibogaïne
Glick SD, Maisonneuve IS
Mechanism of antiaddictive action of ibogaïne.
Annals of New York Academy of Science 1998 ; 844:214-26.
Layer RT, Skolnic P, Bertha CM
Structurally modified ibogaïne analogs exhibit difffering affinities for NMDA receptors.
Eur J Pharmacol 1996 ; 309(2):159-65.
Mash DC, Rovera CA, Buck BE
Medication development of ibogaïne as a pharmacotherapy for drug dependence.
Annals of New York Academy of Science 1998 ; 844:274-92.
Reids MS, Hsu K, Souza KH
Neuropharmacological characterization of local ibogaïne effects on dopamine release.
Journal of Neurotransmission 1996 ; 103(8-9):967-85.
Kava-kava
Heiligenstein E, Guenther G
Over the counter psychotropics : a review of melatonin, St John wort , valerian and kava-kava.
Journal of American College Health 1998 ; 46(6):271-6.
Kétamine
Ellison G
The NMDA antagonists phencyclidine, ketamine and dizocilpine as both behavorial and anatomical model of dementias.
Brain Res 1995 ; 20(2):250-67.
Jansen KL
Ketamine chronic use impair memory.
International Journal of addictions 1990 ; 25(2):133-9.
Mash DC, Rovera CA, Buck BE
Medication development of ibogaïne as a pharmacotherapy for drug dependence.
Annals of New York Academy of Science 1998 ; 844: 274-92.
Murphy JL
Hypertension and pulmonary oedema associated with ketamine administration with a history of substance abuse.
Can J Anaesth 1993 ; 40(2):160-4.
Khat
Abdul Ghani N, Eriksson M, Kristiansson B
The influence of khat chewing on birth weight in full-term infants.
Soc Sci Med 1987 ; 24(5):626-7.
Eriksson M, Abdul Ghani N, Kristiansson B
Khat chewing during pregnancy, effects upon off-spring and some characteristics of the chewers
East Afr Medical J 1991 ; 68(2):106-11.
Nencini P, Ahmed AM
Khat consumption : a pharmacological review.
Drug Alcohol Depend 1989 ; 23(1):19-29.
Giannini AJ, Miller NS, Turner CE
Treatment of khat addiction.
J Subst Abuse Treat 1992 ; 9(4):379-82.
Wilder P, Mathys K, Brenneisen R
Pharmacodynamics and pharmacocinetics of khat : a controlled study.
Clin Pharmacol Ther 1994 ; 55(5):556-62.
Laxatifs
Kornhuber J, Freiss F, Weinacker B
Weight reduction in boulimia nervosa by abuse of thyroid hormones
Nervenarzt 1996 ; 67(7):614-6.
Kruger S, Brauning P
Abuse body weight reducing agents in boulimia nervosa.
Nervenarzt 1995 ; 66(1):66-9.
LSD
Abraham HD, Mamen A
LSD-like panic from risperidone in post-LSD visual disorder.
J Clinical Psychopharmacol 1996 ; 16(3):238-41.
Watts VJ, Lawler CP, Fox DR
LSD and structural analogs pharmacological evaluation at D1 dopamine receptors.
Psychopharmacology 1995 ; 118(4);401-9.
MDMA
Bailly D, Binder P, Choquet M, Facy F, Feger J
Ecstasy : des données biologiques et cliniques aux contextes d'usage.
Expertise collective INSERM, 1998
Galliot-Guilley M, Sueur C, Lebeau B
L'ecstasy et ses sosies.
Presse Med 1997 ; 285(7):358-62.
Henry JA, Fallon JK, Kicman AT
Low-dose MDMA induces vasopressin secretion.
Lancet 1998 ; 351(9118):1784.
Jansen KLR
Ecstasy (MDMA) dependence.
Drug Alcohol Depend 1999 ; 53:121-124.
Lapostolle F, Eliez CA, El Massioui Y
Toxicité de l'ecstasy.
Presse Med 1997 ; 26(38):1881-4.
Meprobamate
Gonzalès JJ, Emmerich AD, Rauch SL
Management of the prescription in dependant adult : case of meprobamate abuse and its treatment.
J Geriatr Psychiatry Neurol 1996 ; 9(2):91-6.
Rho JM, Donevan SD, Rogawski MA
Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate.
J Pharmacol Exp Ther 1997 ; 280(3):1383-91.
Méthyphénidate
RirIe DG, Ririe KL, SethnaNF
Unexpected intercation of methylphenidate with anesthesic agents.
Paediatric Anesthesia 1997 ; 7(1):69-72.
Gay CT, Ryan SG
Paraxysmal kinesigenic dystonia after methyphenydate administration.
J Child Neurol 1994 ; 9(1):45-6.
Nakano H, Iwata Y, Kanegae H
Talc pulmonary granulomatosis caused by intravenous administration of methylphenidate.
Nihon kokyuki gakkai zasshi 1998 ; 36(1):111-5.
Parran TV, Jasinski DR
Intraveinous methylphenidate abuse. Prototype for prescription drug abuse.
Arch Intern Med 1991 ; 151:781-3.
Schmidt RA, Glenny RW, Goldwin JD
Panlobular emphysema inyoung intraveinous Ritalin® abusers.
American Review of Respiratory Disease , 1991 ; 143:649-56.
Modafinil
Ferrano L, Tanganelli S, O'Connor WT
The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of local GABAergique mechanism.
Eur J Pharmacol 1996 ; 306(1-3):33-9.
Gold LH, Balster RL
Evaluation of the cocaïne-like discriminative stimulus effects and reinforcing effects of modafinil.
Psychopharmacology 1996 ; 126(4):286-92.
Morphine
Lassaunière JM
Douleur Morphine et Dépendance.
La Revue Prescrire 1998 ; 18(182):233.
Neurobiologie générale
Degos C F
Pour la pratique.
Rev Prat 1995 ; 45:1351-8.
Koob GF
Neurochemical explanations for addiction.
Hospital Practice A special report : New understanding of drug addiction
Mac Graw Hill : Minneapolis 1997 ; 12-15.
Le Moal M
Neurobiologie de la dépendance
Rev Prat 1995 ; 45:1351-8.
Nestler EJ, Aghajanian GK
Molecular and cellular basis of addiction.
Science 1997 ; 278:58-62.
Nut DJ
Addiction : brain mechanisms and their treatment implications.
Lancet 1996; 437:31-6.
Tassin JP
Drogues dépendances et dopamine
La Recherche 306 : 48-53 fev 1998.
Neuroleptiques
Allain H, Merot JL, Decombe R
Le sevrage brutal des médicaments à visée neuroleptique.
Le Concours Medical 1991 ; 113(2):119-23.
Poyurovsky M, Bergman Y, Shoshani D
Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal.
Clin Neuropharmacol 1998 ; 21:97-100.
Pringuey D, Azorin JM, Bottai T, Perrier E
La dépendance aux antidépresseurs et aux neuroleptiques.
Psychol Med 1989 ; 21(14):2073-5.
Stanilla JK, De Leon J, Simpson GM
Clozapine withdrawal resulting in delirium with psychosis : a report of 3 cases.
J Clin Psychiatry 1997 ; 58:252-255.
Vacheron MN, Gauillard J, Caroli
Le syndrome de sevrage aux neuroleptiques.
Nervure 1998 ; XI Suppl 6:I-IV.
Nexus
Buchanan JF, Brown CR
Designer drugs : a problem in clinical toxicology.
Clinical Toxicology Review 1988 ; 3:1-17.
Nitrites volatiles
Badoual T, Thyrault M, Anguel N, Jallot A, Auzepy P
Intoxication volontaire aiguë par inhalation de " poppers ".
Presse Med 1996 ; 25 (7):304.
Opioïdes
Anonyme
Buprénorphine et substitution : un intérêt confirmé.
La Revue Prescrire 1999 ; 19(192):102-6.
Auriacombe M, Tignol J
Sevrage et prise en charge des toxicomanes aux opiacés.
La Revue du Praticien 1995 ; 45:1383-7.
Bowdle TA
Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.
Drug Saf 1998 ; 19(3):173-89.
O'Connor PG, Ksoten TR
Rapid and ultrarapid opioid detoxification techniques.
JAMA 1998 ; 279:229-34.
Schuckit MA, Segal DS
Opioid drug use.
In Harrisson principles of medicine 2425-9
Weber JC, Kopferschmitt J
Les traitements de substitution chez le toxicomane.
Presse Med 1998 ; 27(39):2088-97.
Woolfolk DR, Holtzman SG
Mu, delta, and kappa receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats.
Drug Alcohol Depend 1997 ; 48:209-220.
Oxybate
Galloway GP, Frederic SL, Staggers JF
Physical dependence on sodium oxybate.
Lancet 1994 ; 343:57.
Louagie HK, Verstraete AG, De Soete CJ, Baetens DG, Call PA
A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid and ethanol.
Clinical Toxicology 1997 ; 35(6) 591-54.
Tunnicliff G
Sites on action of gamma-hydroxybutyrate, a neuroactive drug with abuse potential.
Clinical Toxicology 1997 ; 35 (6) 581-590.
Woolverton WL, Rowlet JK, Winger G
Evaluation of the reinforcing and discriminative stimulus effects of ghydroxubutyrate in rhesus monkeys.
Drug Alcohol Depend 1999 ; 54:137-143.
Phencyclidine
Ellison G
The NMDA antagonists phencyclidine, ketamine and dizocilpineas both behavorial and anatomical model of dementias.
Brain Res 1995 ; 20(2):250-67.
Psilocybine
Beck O, Helander A, Karlson-Stiber C
Presence of phenylethylamine in hallucinogenic Psilocybe mushroom : possible role in adverse reactions.
J Anal Toxicol 1998 ; 22(1):45-9.
Borowiack KS, Ciechanowski K, Waloszczyk P
Psilocybine mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.
J Toxicol Clini Toxicol 1998 ; 36(1-2):47-9.
Franz M, Regele H, Kirchmai M
Magic mushroon : hope for a cheap high resulting in end stage renal faible.
Nephrol Dial Transplant 1996 ; 11(11):2324-7.
Scharfetter C
Positron emission topography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
Neuropsychopharmacology 1997 ; 16(5):357-72.
Smart drugs
Baker LS
Smart drugs :a caution to everybody.
Am J Psychiatry 1996 ; 153(6):844-5.
Solvants
Tenenbien M, Casiro OG, Seshia MM
Neonatal withdrawal from maternal volatile substance abuse.
Archives of Disease in Chilhood Fetal and Neonatal Edition 1996 ; 74(3):204-7.
Stéroïdes anabolisants
Kaschin KB, Kleber HD
Hooked on hormones ? An anabolic steroid addiction hypothesis.
JAMA 1989 ; 262(22):3166-70.
Madea B, Grellner W
Long term cardiovascular effects of anabolic steroids.
Lancet 1998 ; 352:33.
Pope HG, Katz DL
Homicides and near homicide by anabolic steroid users.
J Clin Psychiatry 1990 ; 51:28-31.
Tabac
Benowitz NL
Treating tobacco addiction : nicotine or no nicotine ?
New Engl J Med 1997 ; 337(17):1230-1.
Caraballo RS, Giovino GA, Pechacek TF
Racial and ethnic differences in serum cotinine levels of cigarette smockers.
JAMA 1998 ; 280(2) 135-6.
Jones RT
Tobacco dependence
In Psychopharmacology : the thrid generation of progress
edited by HY Meltzer Raven Press
New York 1987.
Ott A
Smoking and risk of dementia and Alzheimer disease in a population-based cohort study.
Lancet 1998 ; 351:1840-3.
Quinn DI, Wodak A, Day RO
Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatments of illicit drug users.
Clin. Pharmacokinet. 1997 ; 33(5):344-400.
Tredaniel J, Hirsh A
Tabagisme.
Rev Prat 1998 ; 48:433-45.
Uelingher C
Approche cognitivo-comportementale du traitemetn de l'alcoolodépendance.
Rev Prat 1999 ; 49:395-9
Tramadol
Driessen B, Reiman W, Giertz H
Effects of the central analgesic tramadol on the uptake and release of nordrenaline and dopamine in vitro.
Br J Pharmacol 1993 ; 108:806-11.
Jick H, Derby LE, Vasilakis C
The risk of seizures associated with tramadol.
Pharmacotherapy 1998 ; 18(3):607-611.
Meyer PF, Rimash H, Blaha B
Tramadol withdrawal in a neonate.
Eur J Pharmacol 1997 ; 53:159-160.
Vasoconstricteurs
Cocking JGL, Brown MA
Ephedrine abuse causing acute myocardal infarction.
Med J Austr 1997 ; 167:199-200.
Doyle H, Kargin M
Herbal stimulant containing ephedrine has also caused psychosis.
Br Med J 1996 ; 313:756.
Josefson D
Herbal stimulant causes US deaths.
Br Med J 1996 ; 312:1378-9.
Sullivan G
Acute psychosis following intarveinous abuse of pseudopéphédrine.
J Psychopharmacol 1996 ; 10(4)324-5.